|
Department of Internal Medicine
Division
of Gastroenterology
Articles,
Patents and Intellectual Property
Elitsur,
Y, Majumdar, APN, Tureaud, J, Dossescu, J, Neace, C, Velusamy, L and Moshier JA: Tyrosine Kinase and Ornithine
Decarboxylase Activation in Children with Helicobacter Pylori Gastritis. Life
Sciences 65: 1373-1380, 1999.
Jaszewski
R, Khan A, Sarkar FH, Kucuk O, Tobi M, Zagnoon A, Dhar R, Kinzie J, and Majumdar
APN: Folic Acid Inhibition of EGFR Mediated Proliferation in Human Colon Cancer
Cell Lines. American Journal of Physiology (Cell Physiology) 277: C1142-C1148,
1999.
Jiang
C-Y, Gangopadhyay, Berk T, Gallinger S, Cohen Z, Tobi M, Redston M, Bapat B.
STK11/LKB1 germ-line mutations are not identified in most Peutz-Jeghers
Syndrome patients. Clin Genetics
56:136-41, 1999.
Khan,
AJ, Fligiel, SEG, Liu, L, Chandok, A, Jaszewski, R and Majumdar APN:
Induction of EGFR Tyrosine Kinase in the Gastric Mucosa of Diabetic Rats.
Proceedings of the Society for Experimental Biology and Medicine 221:
105-110, 1999.
Mutchnick,
MG, Lindsay, KL, Schiff, ER, Cummings, GD, Appelman, HD, Peleman, RR, Silva, M,
Roach, KC, Simmons, F, Milstein, S, Gordon, SC, Ehrinpreis, MN: Thymosin
(1 treatment of chronic hepatitis B: Results of a phase III multicenter,
randomized double-blind and placebo controlled study. Journal of Viral Hepatitis
6: 397-403, 1999.
Naylor,
PH, Naylor, CW,
Hendrix, S and Leveque, FG: Oral
administration of interferon alpha induces a transient decline in oral mucosal
immunoglobins and an increase in IL-5 concentrations. J Interferon Cytokine
Research 19: 953-9, 1999.
Sondeen
J, Dubick MA, Yu Y, and Majumdar APN: Expression of the Epidermal Growth Factor
(EGF) Receptor in Duodenum from
Rabbits Subjected to Hemorrhage and Renal Ischemia Reperfusion. - Journal of
Laboratory and Clinical Medicine 134:
641-648, 1999.
Tobi
M, Kaila V, Hassan N, Gallinger S, Fligiel S, Hatfield J, Gesell M, Sakr W. MAb
Adnab-9 defines a preneoplastic marker in epithelium at risk for small bowel
adenocarcinoma- Human Pathology 30:467-73, 1999.
Xiao
Z-Q, Yu Y, Khan A, Jaszewski R, Ehrinpreis MN and Majumdar APN: Induction of G1
Checkpoint in the Gastric Mucosa of Aged Rats. American Journal of Physiology
(Gastrointestinal and Liver Physiology) 277: G917-G921, 1999.
Blatt,
L, Mutchnick, MG, Tong, MJ, Tamburro, C, Klion, FM, et al.: Assessment of HCV
RNA and HCV genotype from 6807 chronic HCV patients treated in community
clinical practice in the United States. Journal of Viral Hepatitis (In Press).
Geng
H, Naylor P, Doscescu J, Skunca M, Majumdar APN and Moshier JA: TGF-( is
Required for Full Expression of the Transformed Growth Phenotype of NIH/3T3
Cells Expressing Ornithine Decarboxylase. Carcinogenesis (In Press).
Turner
JD, Liu L, Fligiel SEG, Jaszewski R, and Majumdar APN: Aging Alters Gastric
Mucosal Responses to Epidermal Growth Factor and Transforming Growth Factor (.
American Journal of Physiology. (Gastrointest. Liver Physiol.) (In Press).
Xiao
Z-H, and Majumdar APN: Induction of Transcriptional Activity of AP-1 and NF-(B
in the Gastric Mucosa During Aging. American
Journal of Physiology (Gastrointest. Liver Physiol.) -
(In Press). Method of Treating Hepatitis C in Non-Responders to
Interferon Treatment United States Patent Number 6,001,799 December 14, 1999
Books,
Chapters and Reviews
Jaszewski
R, Ehrinpreis MN and Majumdar APN: Aging and Cancer of the Stomach and Colon.
Frontiers in Bioscience 4: 322-328, 1999.
Majumdar
APN: Nutrition and Gastrointestinal Cancer. In: Medicine in the Millenium (Ray P
ed.), Marks Media Services, Calcutta, India.
Mutchnick
MG: Acute and Chronic Hepatitis B.
In Gastroenterology & Hepatology, the Comprehensive Visual Reference: The
Liver. W.C. Maddrey, Editor,
Current Medicine, Philadelphia, 2000. (In
Press).
Naylor,
PH. Zadaxin (thymosin alpha1) for
the treatment of viral hepatitis. Expert
Opinion on Investigational Drugs 8:
281-287. 1999
Tobi
M. Polyps as Biomarkers.
Frontiers in Bioscience- Online Peer-Review Journal 4:d329-388, 1999.
HYPERLINK Òhttp://www.bioscience.orgÓ #www.bioscience.org
Abstracts,
Letters to the Editor and Articles in Non-Refereed Journals
Akhras,
J, Kinzie, J: Enteroadherent bacteria and diarrhea in aids.
Gastroenterology 94:667A, 1999. (Presented
at ACG, Phoenix, Arizona 10/99)
Khalid
M, Tobi M, Bialor B. A Case Report
of Meningococcemia in a Jail Inmate with Advanced Liver Disease. J Gen Int Med
14;(2):183,1999
Khan
A, Jaszewski R, Sarkar FH, Kucuk O, Ravishankar P, and Majumdar APN: Regulation
of Folic Acid Induced Inhibition of CaCo-2 Cell Proliferation. 100th Annual
Meeting of the American Gastroenterological Association (AGA), Orlando, FL.
Gastroenterology 116: A1913, 1999.
Kinzie,
JL. Naylor, PH. Ehrinpreis, MN, Khan, N, Siddiqui, FA, Peleman, RR, Mutchnick,
MG: Reluctance of urban clinic patients to undergo treatment with
interferon-alpha. Hepatology 30: 266A, 1999.
(Presented at AASLD, Dallas, TX 11/7/99).
Kulkarni,
P, Singal, S, Kinzie, J: Pancreatic sarcoidosis presenting with pancreatic mass
producing billiary obstruction and role of EUS in its diagnosis.
Gastroenterology 94:219A, 1999.
Kulkarni,
P, Kinzie, J: Esophageal stenosis
at site of esophageal-colonic anastomosis in epidermolysis bullosa, a challenge
for endoscopic management. Gastroenterology,
V116 (supplement) G0979, 04/99.
Kulkarni,
P, Kinzie, J: Methylene blue
chromendography in the management of gastric misperfusion from hepatic
intraarterial chemotherapy device. Gastroenterology, V116 (supplement) G1950,
04/99.
Liu,
L, Khan A, Jaszewski R and Majumdar APN: Aging Enhances Ligand-Induced
Internalization of EGF-Receptor (EGFR) in the Gastric Mucosa. 100th Annual
Meeting of the American
Gastroenterological Association (AGA),
Orlando, FL. Gastroenterology 116: A2469, 1999.
Madhira
M, Tobi M. Primary KaposiÕs Sarcoma of small bowel: Massive gastrointestinal
bleeding as initial presentation. American Journal of Gastroenterology 94:2717,
1999.
Naylor,
PH, Brown, KA, Gordon, SC, Moonka, D, Silverman, AL, Kinzie, JL, Ehrinpreis, MN,
Peleman, RR, Mutchnick, MG: Response
to retreatment with interferon/ribavirin in caucasian and African American
relapsers and nonresponders. Hepatology
30: 373A, 1999 (Presented at AASLD, Dallas, TX
11/8/99).
Naylor,
PH, Naylor, CW, Hendrix, S, and LeVeque, FG: Oral administration of interferon
alpha induces a transient decline in oral mucosal immunoglobins and an increase
in IL-5 concentrations. An. Assoc.
for Cancer Research, Proceedings
40; A3802, 1999.
Naylor,
PH, Renaud-Mauer, C, Shahzad S, Alloju M, and Tobi, M:
Hemoccult cards for screening with a monoclonal antibody to a
premalignant colon cancer marker (Adnab-9). American Assoc. for Cancer Research,
Proceedings 40: A386, 1999
Naylor,
PH, Podzorski, R, Dhar R, Ehrinpreis,
MN, Kinzie, JL, Siddiqui, F and Mutchnick, MG:
Two laboratory methods for measuring serum HCV RNA in patients with
hepatitis C are equal with respect to determining and predicting end of
treatment response to interferon therapy. Antiviral
Therapy 4 (supplement 4) A87, 1999.
Siddiqui,
F, Naylor, PH, Ehrinpreis, MN, Peleman, RR, Kinzie, JL, Mutchnick, MG:
Induction interferon treatment of African-Americans with chronic
hepatitis C results in an enhanced response comparable to caucasians given
standard interferon therapy. Gastroenterology 116: A820, 1999. (Presented at DDW,
Orlando, FL 5/16/99).
Tobi
M, Hatfield J, Fligiel SE, Renaud-Maher C, Sochacki P. Enhanced
Immunohistochemical Expression of Adnab-9 Epitope in Frozen Sections of
Adenomatous Polyps. Proceedings of the American Association for Cancer Research
;40:58, 1999.
Tobi
M, Gollahon L, Lawson M. Lower
Telomerase Activity in Inflammatory Bowel Disease: An Etiologic Factor?
Gastroenterology 116:A669, 1999
Tobi
M, Hatfield J, Adsay V, Galagan K,
Kozarek R, Inagaki M, Kasai S, Tokusashi Y, Obara T, Lough J, Barkun A, Jabbari M, Hruban R, Lawson M, Ruebner B, Sheikh
R,. Fligiel S. Adnab-9, A
Prognostic Marker in Pancreatic Intraductal Papillary Mucin-Producing Neoplasms?
Gastroenterology 116:A669,1999
Ullah,
N, Siddiqui, FA, Naylor, PH, Kinzie, JL, Ehrinpreis, MN, Peleman, RR, Mutchnick,
MG: Presence of hepatitis B virus core antibodies (Anti-HBC) in chronic
hepatitis C patients is predictive of a decreased end of treatment response (ETR)
to interferon. Hepatology 30: 195A,
1999. (Presented at AASLD, Dallas,
TX 11/6/99).
Yeh
R, Gupta B, Parks M, Boparai J, Renaud-Maher C, Tobi M. Effect of Percutaneous, Endoscopic Gastrostomy Tube Placement
on the Outcome Of the Fecal Occult Blood Test. Gastroenterology 116:A363, 1999
Yu
Y, Moshier JA, Siddiq F, and Majumdar APN: Cloning of a Novel EGFR-Related
Peptide (ERRP): A Putative Negative Regulator of EGFR. 100th Annual Meeting of
the American Gastroenterological Association
(AGA), Orlando, FL. Gastroenterology 116: A2865, 1999.
Akhras,
J, Naylor, PH, Kiranmaia, J, Hemacha, A, Fliegiel, S and
Jaszewski, R: Demographics and treatment
response of an urban veteran population infected with the Hepatitis C virus.
Gastroenterology (In press)
Khalifa-Al-Saleh,
A, Naylor, PH, Kinzie, JL, Ehrinpreis, MN, Siddiqui, F, Dhar, R, Turner, JR, and
Mutchnick, MG: End of treatment
response (ETR) to Intron A monotherapy in chronic hepatitis C is similar in
patients with normal and elevated ALT. Proceedings
of the 10th International Symposium on Viral Hepatitis and Liver Disease (in
press).
Mutchnick,
MG, Naylor, PH, Upfal, MJ: Hepatitis C screening of urban emergency response
personnel. Gastroenterology (In
press).
Naylor,
PH, Kinzie, JL, Ehrinpreis, MN, Siddiqui, R, Dhar, R, and Mutchnick, MG:
Retreatment of interferon failures with combination therapy: log drop
after 12 weeks of monotherapy predicts ETR to combination.
Proceedings of the 10th International Symposium on Viral Hepatitis and
Liver Diseases (in press)
Ullah
N, hatfield S, Fligiel S, David D, Ruebner B, Sheikh R, Lawson M, Tobi M.
Adnab-9 staining in mixed adenomatous colonic polyps.
Proceed. Am. Assoc. Can. Res. (In press)
Weidler,
N, Naylor, PH, Patel, C, Chilukuri, S, Mendu, S, Janisse, J, Dhar, R, Ehrinpreis,
M, Kinzie, J, Siddiqui, F, Turner, J, Mutchnick, MG:
Demographical and biochemical influences on quality of life scores in
urban patients with Hepatitis C. Gastroenterology
(in press).
Back
to Internal Medicine
|